CEACAM5 and neoplasm: Treatment of hematopoietic stem cell humanized NOG mice (HSC-NOG) bearing human MKN-45 tumor cells with CEA-TCB 2.5 mg/kg twice weekly reduced tumor growth by 62% compared with vehicle treated controls (Figure 1A).